Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
Ryan S. Lee, … , Gad Getz, Charles W.M. Roberts
Ryan S. Lee, … , Gad Getz, Charles W.M. Roberts
Published July 17, 2012
Citation Information: J Clin Invest. 2012;122(8):2983-2988. https://doi.org/10.1172/JCI64400.
View: Text | PDF
Brief Report Oncology Article has an altmetric score of 8

A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

  • Text
  • PDF
Abstract

Cancer is principally considered a genetic disease, and numerous mutations are thought essential to drive its growth. However, the existence of genomically stable cancers and the emergence of mutations in genes that encode chromatin remodelers raise the possibility that perturbation of chromatin structure and epigenetic regulation are capable of driving cancer formation. Here we sequenced the exomes of 35 rhabdoid tumors, highly aggressive cancers of early childhood characterized by biallelic loss of SMARCB1, a subunit of the SWI/SNF chromatin remodeling complex. We identified an extremely low rate of mutation, with loss of SMARCB1 being essentially the sole recurrent event. Indeed, in 2 of the cancers there were no other identified mutations. Our results demonstrate that high mutation rates are dispensable for the genesis of cancers driven by mutation of a chromatin remodeling complex. Consequently, cancer can be a remarkably genetically simple disease.

Authors

Ryan S. Lee, Chip Stewart, Scott L. Carter, Lauren Ambrogio, Kristian Cibulskis, Carrie Sougnez, Michael S. Lawrence, Daniel Auclair, Jaume Mora, Todd R. Golub, Jaclyn A. Biegel, Gad Getz, Charles W.M. Roberts

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2009 Total
Citations: 4 17 13 17 11 17 17 10 16 20 19 21 20 2 1 205
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (205)

Title and authors Publication Year
SMARCB1 ‐deficient malignant melanocytic uveal tumours: a new neural crest‐derived tumour entity with SMARCB1 ‐related germline predisposition
Cyrta J, Masliah\u2010Planchon J, Hoare O, Brillet R, Andrianteranagna M, Sohier P, Cardoen L, Bouchoucha Y, Filser M, Goncalves A, Caly M, Fréneaux P, Stefanaki K, Pefkianaki M, Moschovi M, Matet A, Cassoux N, Lumbroso\u2010Le Rouic L, Gauthier\u2010Villars M, Stern M, Vincent\u2010Salomon A, Rodrigues M, Bourdeaut F
The Journal of Pathology 2025
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.
Perotti D, O'Sullivan MJ, Walz AL, Davick J, Al-Saadi R, Benedetti DJ, Brzezinski J, Ciceri S, Cost NG, Dome JS, Drost J, Evageliou N, Furtwängler R, Graf N, Maschietto M, Mullen EA, Murphy AJ, Ortiz MV, van der Beek JN, Verschuur A, Wegert J, Williams R, Spreafico F, Geller JI, van den Heuvel-Eibrink MM, Hong AL
Nature reviews. Urology 2025
SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and Ongoing Clinical Trials
Shakerdi AL, Pidgeon GP
Metabolites 2025
SIRT2 regulates the SMARCB1 loss-driven differentiation block in ATRT
Alimova I, Wang D, DeSisto J, Danis E, Lakshmanachetty S, Prince E, Murdock G, Pierce A, Donson A, Balakrishnan I, Serkova N, Lin H, Foreman NK, Dahl N, Venkataraman S, Vibhakar R
Molecular cancer research : MCR 2025
Epigenetic regulation in cancer.
Gu M, Ren B, Fang Y, Ren J, Liu X, Wang X, Zhou F, Xiao R, Luo X, You L, Zhao Y
2024
Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1
Jones CA, Wang J, Evans JR, Sisk HR, Womack CB, Liu Q, Tansey WP, Weissmiller AM
Cancers 2024
Translational Aspects of Epithelioid Sarcoma – Current Consensus
Grunewald TG, Postel-Vinay S, Nakayama RT, Berlow NE, Bolzicco A, Cerullo V, Dermawan JK, Frezza AM, Italiano A, Jin JX, Loarer FL, Martin-Broto J, Pecora A, Perez-Martinez A, Tam YB, Tirode F, Trama A, Pasquali S, Vescia M, ortmann L, Wortmann M, Yoshida A, Webb K, Huang PH, Keller C, Antonescu CR
Clinical cancer research 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S, Yue H, Myers JA, Carter RD, Robertson AN, Mittal P, Zhu Z, Hansen BS, Donovan KA, Hunkeler M, Rosikiewicz W, Wu Z, McReynolds MG, Roy Burman SS, Schmoker AM, Mageed N, Brown SA, Mobley RJ, Partridge JF, Stewart EA, Pruett-Miller SM, Nabet B, Peng J, Gray NS, Fischer ES, Roberts CWM
Nature 2024
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
Bielamowicz KJ, Littrell MB, Albert GW, Parker LS, Jayappa S, Aldape K, Gokden M
Journal of Neuro-Oncology 2024
Developmental origins shape the paediatric cancer genome.
Chen X, Yang W, Roberts CWM, Zhang J
Nature reviews. Cancer 2024
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
Kim SS, Moghe M, Rait A, Donaldson K, Harford JB, Chang EH
International Journal of Nanomedicine 2024
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression
Mittal P, Myers JA, Carter RD, Radko-Juettner S, Malone HA, Rosikiewicz W, Robertson AN, Zhu Z, Narayanan IV, Hansen BS, Parrish M, Bhanu NV, Mobley RJ, Rehg JE, Xu B, Drosos Y, Pruett-Miller SM, Ljungman M, Garcia BA, Wu G, Partridge JF, Roberts CW
Nature Communications 2024
Chromatin remodellers as therapeutic targets.
Malone HA, Roberts CWM
Nature reviews. Drug discovery 2024
The Biological Clock of Liver Metabolism in Metabolic Dysfunction-Associated Steatohepatitis Progression to Hepatocellular Carcinoma
Rajan PK, Udoh UA, Finley R, Pierre SV, Sanabria J
Biomedicines 2024
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
Golbourn B, Ho B, Bondoc A, Luck A, Fan X, Richardson E, Marcellus R, Prakesch M, Halbert M, Agrawal N, Smith C, Huang A, Rutka JT
Neuro-oncology 2024
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
Merk DJ, Tsiami F, Hirsch S, Walter B, Haeusser LA, Maile JD, Stahl A, Jarboui MA, Lechado-Terradas A, Klose F, Babaei S, Admard J, Casadei N, Roggia C, Spohn M, Schittenhelm J, Singer S, Schüller U, Piccioni F, Persky NS, Claassen M, Tatagiba M, Kahle PJ, Root DE, Templin M, Tabatabai G
Genome Biology 2024
Progress Toward Epigenetic Targeted Therapies for Childhood Cancer
Liapodimitri A, Tetens AR, Craig-Schwartz J, Lunsford K, Skalitzky KO, Koldobskiy MA
Cancers 2024
Absence of SMARCB1 in rhabdoid tumor cells increases sensitivity to translation inhibition and alters translation efficiency of specific mRNAs
Nguyen LT, Hains AE, Aziz-Zanjani MO, Dalsass M, Farooqee SB, Lu Y, Jackson PK, Van Rechem C
The Journal of Biological Chemistry 2024
Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumors
Fleischmann LS, Nemes K, Glaser S, Kouroukli AG, Boros M, Bens S, Dahlum S, Kretzmer H, Oyen F, Gerss J, Hasselblatt M, Frühwald MC, Siebert R
Neuro-Oncology 2024
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Kes MM, Morales-Rodriguez F, Zaal EA, de Souza T, Proost N, van de Ven M, van den Heuvel-Eibrink MM, Jansen JW, Berkers CR, Drost J
Cell Reports Medicine 2024
Lineage-Selective Dependencies in Pediatric Cancers
Ritter KE, Durbin AD
Cold Spring Harbor perspectives in medicine 2024
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Alva E, Rubens J, Chi S, Rosenberg T, Reddy A, Raabe EH, Margol A
Neoplasia (New York, N.Y.) 2023
SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression
Walhart TA, Vacca B, Hepperla AJ, Hamad SH, Petrongelli J, Wang Y, McKean EL, Moksa M, Cao Q, Yip S, Hirst M, Weissman BE
The American Journal of Pathology 2023
(mis)-Targeting of SWI/SNF complex(es) in cancer.
Reddy D, Bhattacharya S, Workman JL
Cancer metastasis reviews 2023
Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications
Dang DD, Rosenblum JS, Shah AH, Zhuang Z, Doucet-O\u2019Hare TT
Cancers 2023
The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.
Navickas SM, Giles KA, Brettingham-Moore KH, Taberlay PC
Oncogene 2023
Current advances in immunotherapy for atypical teratoid rhabdoid tumor (ATRT)
Tran S, Plant-Fox AS, Chi SN, Narendran A
Neuro-Oncology Practice 2023
Modeling human brain rhabdoid tumor by inactivating tumor suppressor genes in induced pluripotent stem cells
Hua T, Xue Y, Sarker DB, Kiran S, Li Y, Sang QX
Bioactive Materials 2023
Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors.
Kuwahara Y, Iehara T, Matsumoto A, Okuda T
Cancer Medicine 2023
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
Lobón-Iglesias MJ, Andrianteranagna M, Han ZY, Chauvin C, Masliah-Planchon J, Manriquez V, Tauziede-Espariat A, Turczynski S, Bouarich-Bourimi R, Frah M, Dufour C, Blauwblomme T, Cardoen L, Pierron G, Maillot L, Guillemot D, Reynaud S, Bourneix C, Pouponnot C, Surdez D, Bohec M, Baulande S, Delattre O, Piaggio E, Ayrault O, Waterfall JJ, Servant N, Beccaria K, Dangouloff-Ros V, Bourdeaut F
Nature Communications 2023
Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor.
Wei CH, Wang E, Sadimin E, Rodriguez-Rodriguez L, Agulnik M, Yoon J, LoBello J, Szelinger S, Anderson C
Gynecologic Oncology Reports 2023
Extradural malignant rhabdoid tumor of the spine in children: A case-based review.
Vigneul E, Rooijakkers H, Joris V, Daoud L, Van Damme A, Raftopoulos C
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2023
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Nguyen VT, Tessema M, Weissman BE
Cancer treatment and research 2023
A Rare Case of Rhabdoid Pancreatic Carcinoma: Prolonged Disease-Free Survival Following Upfront Resection and Adjuvant Chemotherapy
Land G, Van Haeringen B, Cooper C, Andelkovic V, O'Rourke T
Cureus 2023
Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells
A Florian, C Woodley, J Wang, B Grieb, M Slota, K Guerrazzi, C Hsu, B Matlock, D Flaherty, S Lorey, S Fesik, G Howard, Q Liu, A Weissmiller, W Tansey
2022
Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors
I Alimova, D Wang, E Danis, A Pierce, A Donson, N Serkova, K Madhavan, S Lakshmanachetty, I Balakrishnan, N Foreman, S Mitra, S Venkataraman, R Vibhakar
International journal of oncology 2022
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
C Ngo, S Postel-Vinay
Biomedicines 2022
The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells
K Moe, J Maxwell, J Wang, C Jones, G Csaki, A Florian, A Romer, D Bryant, A Farone, Q Liu, W Tansey, A Weissmiller
Oncogenesis 2022
Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors
Groves A, Clymer J, Filbin MG
Pharmaceuticals 2022
Extracellular Vesicles: A New Source of Biomarkers in Pediatric Solid Tumors? A Systematic Review
Lak NS, van der Kooi EJ, Enciso-Martinez A, Lozano-Andrés E, Otto C, Wauben MH, Tytgat GA
Frontiers in Oncology 2022
Recent Advances in Renal Medullary Carcinoma
Su Y, Hong AL
International journal of molecular sciences 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial
Parsons DW, Janeway KA, Patton DR, Winter CL, Coffey B, Williams PM, Roy-Chowdhuri S, Tsongalis GJ, Routbort M, Ramirez NC, Saguilig L, Piao J, Alonzo TA, Berg SL, Fox E, Hawkins DS, Abrams JS, Mooney M, Takebe N, Tricoli JV, Seibel NL
Journal of Clinical Oncology 2022
Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma
Tourigny DS, Zucker M, Kim M, Russo P, Coleman J, Lee CH, Carlo MI, Chen YB, Hakimi AA, Kotecha RR, Reznik E
Frontiers in Oncology 2022
Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation
Jones CA, Tansey WP, Weissmiller AM
2022
Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Ferrari A, Brennan B, Casanova M, Corradini N, Berlanga P, Schoot RA, Ramirez-Villar GL, Safwat A, Guillen Burrieza G, Dall\u2019Igna P, Alaggio R, Lyngsie Hjalgrim L, Gatz SA, Orbach D, van Noesel MM
Cancer management and research 2022
NSD1 mediates antagonism between SWI/SNF and Polycomb complexes and is required for transcriptional activation upon EZH2 inhibition
Drosos Y, Myers JA, Xu B, Mathias KM, Beane EC, Radko-Juettner S, Mobley RJ, Larsen ME, Piccioni F, Ma X, Low J, Hansen BS, Peters ST, Bhanu NV, Dhanda SK, Chen T, Upadhyaya SA, Pruett-Miller SM, Root DE, Garcia BA, Partridge JF, Roberts CW
Molecular Cell 2022
How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care.
Cipri S, Abenavoli L, Boccuto L, Del Baldo G, Mastronuzzi A
2022
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Islam SM, Díaz-Gay M, Wu Y, Barnes M, Vangara R, Bergstrom EN, He Y, Vella M, Wang J, Teague JW, Clapham P, Moody S, Senkin S, Li YR, Riva L, Zhang T, Gruber AJ, Steele CD, Otlu B, Khandekar A, Abbasi A, Humphreys L, Syulyukina N, Brady SW, Alexandrov BS, Pillay N, Zhang J, Adams DJ, Martincorena I, Wedge DC, Landi MT, Brennan P, Stratton MR, Rozen SG, Alexandrov LB
2022
Dedifferentiation and in vivo reprogramming of committed cells in wound repair (Review).
Guo Y, Wu W, Yang X, Fu X
Molecular medicine reports 2022
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK, Singer S, Tap WD, Nacev BA, Chi P, Wexler LH, Ortiz MV, Gounder M, Antonescu CR
Modern Pathology 2022
Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets
Rechberger JS, Nesvick CL, Daniels DJ
Expert opinion on therapeutic targets 2022
Synergy between Toxoplasma gondii type I Δ GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
YC Zhu, HM Elsheikha, JH Wang, S Fang, JJ He, XQ Zhu, J Chen
Journal for ImmunoTherapy of Cancer 2021
Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications
S Chen, X Deng, H Sheng, Y Rong, Y Zheng, Y Zhang, J Lin
Molecular Therapy — Nucleic Acids 2021
In vitro Modeling of Embryonal Tumors
L Custers, I Paassen, J Drost
Frontiers in Cell and Developmental Biology 2021
Global Chromatin Changes Resulting from Single-Gene Inactivation—The Role of SMARCB1 in Malignant Rhabdoid Tumor
C Kenny, E OMeara, M Ulaş, K Hokamp, MJ OSullivan
Cancers 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
A Marcu, A Schlosser, A Keupp, N Trautwein, P Johann, M Wölfl, J Lager, CM Monoranu, JS Walz, LM Henkel, J Krauß, M Ebinger, M Schuhmann, UW Thomale, T Pietsch, E Klinker, PG Schlegel, F Oyen, Y Reisner, HG Rammensee, M Eyrich
Journal for ImmunoTherapy of Cancer 2021
A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
J Li, TS Mulvihill, L Li, JJ Barrott, ML Nelson, L Wagner, IC Lock, A Pozner, SL Lambert, BB Ozenberger, MB Ward, AH Grossmann, T Liu, A Banito, BR Cairns, KB Jones
Cancer Discovery 2021
Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
MT Elghetany, JM Ho, LH Shi-Qi, S Karthik, JM Su, Q Lin, YC Du, J Shen, WY Chow, CC Lau, A Adesina, A Major, A Erdreich-Epstein, KM Hui, XN Li, WY Teo
Scientific Reports 2021
Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy
WC Chong, WS Jayasekara, VG Vaghjiani, S Parackal, C Sun, D Popovski, EM Algar, R Firestein, PJ Wood, S Khan, A Huang, DM Ashley, P Downie, JE Cain
Cancers 2021
DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker
N Azizgolshani, CL Petersen, Y Chen, JJ Levy, LA Salas, L Perreard, LN Nguyen, BC Christensen
Clinical Epigenetics 2021
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
GD Baldo, R Carta, I Alessi, P Merli, E Agolini, M Rinelli, L Boccuto, GM Milano, A Serra, A Carai, F Locatelli, A Mastronuzzi
Frontiers in Oncology 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
SA Upadhyaya, GW Robinson, A Onar-Thomas, BA Orr, P Johann, G Wu, CA Billups, RG Tatevossian, SK Dhanda, A Srinivasan, A Broniscer, I Qaddoumi, A Vinitsky, GT Armstrong, AE Bendel, T Hassall, S Partap, PG Fisher, JR Crawford, M Chintagumpala, E Bouffet, S Gururangan, R Mostafavi, RP Sanders, P Klimo, Z Patay, DJ Indelicato, KE Nichols, FA Boop, TE Merchant, M Kool, DW Ellison, A Gajjar
Clinical cancer research 2021
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
M Garcia-Moure, M Gonzalez-Huarriz, S Labiano, E Guruceaga, E Bandres, M Zalacain, L Marrodan, C de Andrea, M Villalba, N Martinez-Velez, V Laspidea, M Puigdelloses, JG Perez-Larraya, I Iñigo-Marco, R Stripecke, JA Chan, EH Raabe, M Kool, C Gomez-Manzano, J Fueyo, A Patiño-García, MM Alonso
Clinical cancer research 2020
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
J Theruvath, E Sotillo, CW Mount, CM Graef, A Delaidelli, S Heitzeneder, L Labanieh, S Dhingra, A Leruste, RG Majzner, P Xu, S Mueller, DW Yecies, MA Finetti, D Williamson, PD Johann, M Kool, S Pfister, M Hasselblatt, MC Frühwald, O Delattre, D Surdez, F Bourdeaut, S Puget, S Zaidi, SS Mitra, S Cheshier, PH Sorensen, M Monje, CL Mackall
Nature Medicine 2020
The SWI/SNF complex in cancer — biology, biomarkers and therapy
P Mittal, CW Roberts
Nature Reviews Clinical Oncology 2020
SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors
P Panwalkar, D Pratt, C Chung, D Dang, P Le, D Martinez, JM Bayliss, KS Smith, M Adam, S Potter, PA Northcott, L Mascarenhas, J Shows, B Pawel, A Margol, A Huang, AR Judkins, S Venneti
Neuro-Oncology 2020
Targeting epigenetics in sarcomas through EZH2 inhibition
A Italiano
Journal of Hematology & Oncology 2020
Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors
LM Hoffman, EA Richardson, B Ho, A Margol, A Reddy, L Lafay-Cousin, S Chi, I Slavc, A Judkins, M Hasselblatt, F Bourdeaut, MC Frühwald, R Vibhakar, E Bouffet, A Huang
Neuro-Oncology 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
P Msaouel, GG Malouf, X Su, H Yao, DN Tripathi, M Soeung, J Gao, P Rao, C Coarfa, CJ Creighton, JP Bertocchio, S Kunnimalaiyaan, AS Multani, J Blando, R He, DD Shapiro, L Perelli, S Srinivasan, F Carbone, PG Pilié, M Karki, RN Seervai, BH Vokshi, D Lopez-Terrada, EH Cheng, X Tang, W Lu, II Wistuba, TC Thompson, I Davidson, V Giuliani, K Schlacher, A Carugo, TP Heffernan, P Sharma, JA Karam, CG Wood, CL Walker, G Genovese, NM Tannir
Cancer Cell 2020
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics
CL Nesvick, L Lafay-Cousin, A Raghunathan, E Bouffet, AA Huang, DJ Daniels
Journal of Neuro-Oncology 2020
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
AD Parisian, T Koga, S Miki, PD Johann, M Kool, JR Crawford, FB Furnari
Genes & development 2020
Structural Insights into the Evolutionarily Conserved BAF Chromatin Remodeling Complex
RD Marcum, AA Reyes, Y He
Biology : open access journal 2020
The epigenomics of sarcoma
BA Nacev, KB Jones, AM Intlekofer, JS Yu, CD Allis, WD Tap, M Ladanyi, TO Nielsen
Nature Reviews Cancer 2020
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
TP Howard, EM Oberlick, MG Rees, TE Arnoff, MT Pham, L Brenan, M DoCarmo, AL Hong, G Kugener, HC Chou, Y Drosos, KM Mathias, P Ramos, B Seashore-Ludlow, AO Giacomelli, X Wang, BB Freeman, K Blankenship, L Hoffmann, HL Tiv, PC Gokhale, CM Johannessen, EA Stewart, SL Schreiber, WC Hahn, CW Roberts
Clinical cancer research 2020
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
A Perla, L Fratini, PS Cardoso, C Nör, AT Brunetto, AL Brunetto, CB de Farias, M Jaeger, R Roesler
Frontiers in Cell and Developmental Biology 2020
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
D Holdhof, PD Johann, M Spohn, M Bockmayr, S Safaei, P Joshi, J Masliah-Planchon, B Ho, M Andrianteranagna, F Bourdeaut, A Huang, M Kool, SA Upadhyaya, AE Bendel, D Indenbirken, WD Foulkes, JW Bush, D Creytens, U Kordes, MC Frühwald, M Hasselblatt, U Schüller
Acta Neuropathologica 2020
Human Pluripotent Stem Cell Fate Regulation by SMARCB1
I Carmel-Gross, E Levy, L Armon, O Yaron, HW Ben-Asher, A Urbach
Stem Cell Reports 2020
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers
SJ Forrest, A Al-Ibraheemi, D Doan, A Ward, CM Clinton, J Putra, RS Pinches, C Kadoch, SN Chi, SG DuBois, PJ Leavey, NR LeBoeuf, E Mullen, N Collins, AJ Church, KA Janeway
Clinical cancer research 2020
Evolving insights: how DNA repair pathways impact cancer evolution
J Zhou, XA Zhou, N Zhang, J Wang
Cancer biology & medicine 2020
Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven Medulloblastoma
Bethany, L Veo, Etienne Danis, Angela Pierce, Ismail Sola, Dong Wang, Nicholas K Foreman, Jian Jin, Anqi Ma, Natalie Serkova, Sujatha Venkataraman, Rajeev Vibhakar
JCI Insight 2019
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
TP Howard, TE Arnoff, MR Song, AO Giacomelli, X Wang, AL Hong, NV Dharia, S Wang, F Vazquez, MT Pham, AM Morgan, F Wachter, GH Bird, G Kugener, EM Oberlick, MG Rees, HL Tiv, JH Hwang, KH Walsh, A Cook, JM Krill-Burger, A Tsherniak, PC Gokhale, PJ Park, K Stegmaier, LD Walensky, WC Hahn, CW Roberts
Cancer research 2019
Inhibition of MYC by the SMARCB1 tumor suppressor
AM Weissmiller, J Wang, SL Lorey, GC Howard, E Martinez, Q Liu, WP Tansey
Nature Communications 2019
Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
RC Smith, V Tabar
Cell Stem Cell 2019
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
A Carugo, R Minelli, L Sapio, M Soeung, F Carbone, FS Robinson, J Tepper, Z Chen, S Lovisa, M Svelto, S Amin, S Srinivasan, ED Poggetto, S Loponte, F Puca, P Dey, GG Malouf, X Su, L Li, D Lopez-Terrada, D Rakheja, AJ Lazar, GJ Netto, P Rao, A Sgambato, A Maitra, DN Tripathi, CL Walker, JA Karam, TP Heffernan, A Viale, CW Roberts, P Msaouel, NM Tannir, GF Draetta, G Genovese
Cancer Cell 2019
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
KA Orlando, V Nguyen, JR Raab, T Walhart, BE Weissman
Expert Review of Anticancer Therapy 2019
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
AL Hong, YY Tseng, JA Wala, WJ Kim, BD Kynnap, MB Doshi, G Kugener, GJ Sandoval, TP Howard, J Li, X Yang, M Tillgren, M Ghandi, A Sayeed, R Deasy, A Ward, B McSteen, KM Labella, P Keskula, A Tracy, C Connor, CM Clinton, AJ Church, BD Crompton, KA Janeway, BV Hare, D Sandak, O Gjoerup, P Bandopadhayay, PA Clemons, SL Schreiber, DE Root, PC Gokhale, SN Chi, EA Mullen, CW Roberts, C Kadoch, R Beroukhim, KL Ligon, JS Boehm, WC Hahn
eLife 2019
BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors
X Wang, S Wang, EC Troisi, TP Howard, JR Haswell, BK Wolf, WH Hawk, P Ramos, EM Oberlick, EP Tzvetkov, F Vazquez, WC Hahn, PJ Park, CW Roberts
Nature Communications 2019
A case of intraplacental gestational choriocarcinoma; characterised by the methylation pattern of the early placenta and an absence of driver mutations
P Savage, D Monk, JR Mora, N van der Westhuizen, J Rauw, A Tinker, W Robinson, Q Song, MJ Seckl, RA Fisher
BMC Cancer 2019
Microfluidic epigenomic mapping technologies for precision medicine
C Deng, LB Naler, C Lu
Lab on a Chip 2019
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer
AP Bracken, GL Brien, CP Verrijzer
Genes & development 2019
NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
JH Phi, CH Sun, SH Lee, S Lee, I Park, SA Choi, SH Park, JY Lee, KC Wang, SK Kim, H Yun, CK Park
BMC Cancer 2019
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine
SZ Wang, B Poore, J Alt, A Price, SJ Allen, AR Hanaford, H Kaur, BA Orr, BS Slusher, CG Eberhart, EH Raabe, JA Rubens
Clinical cancer research 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors
EM Oberlick, MG Rees, B Seashore-Ludlow, F Vazquez, GM Nelson, NV Dharia, BA Weir, A Tsherniak, M Ghandi, JM Krill-Burger, RM Meyers, X Wang, P Montgomery, DE Root, JM Bieber, S Radko, JH Cheah, CS Hon, AF Shamji, PA Clemons, PJ Park, MA Dyer, TR Golub, K Stegmaier, WC Hahn, EA Stewart, SL Schreiber, CW Roberts
Cell Reports 2019
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
HJ Chun, PD Johann, K Milne, M Zapatka, A Buellesbach, N Ishaque, M Iskar, S Erkek, L Wei, B Tessier-Cloutier, J Lever, E Titmuss, JT Topham, R Bowlby, E Chuah, KL Mungall, Y Ma, AJ Mungall, RA Moore, MD Taylor, DS Gerhard, SJ Jones, A Korshunov, M Gessler, K Kerl, M Hasselblatt, MC Frühwald, EJ Perlman, BH Nelson, SM Pfister, MA Marra, M Kool
Cell Reports 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors
MC Frühwald, M Hasselblatt, K Nemes, S Bens, M Steinbügl, PD Johann, K Kerl, P Hauser, E Quiroga, P Solano-Paez, V Biassoni, MJ Gil-da-Costa, M Perek-Polnik, M van de Wetering, D Sumerauer, J Pears, N Stabell, S Holm, H Hengartner, NU Gerber, M Grotzer, J Boos, M Ebinger, S Tippelt, W Paulus, R Furtwängler, P Hernáiz-Driever, H Reinhard, S Rutkowski, PG Schlegel, I Schmid, RD Kortmann, B Timmermann, M Warmuth-Metz, U Kordes, J Gerss, K Nysom, R Schneppenheim, R Siebert, M Kool, N Graf
Neuro-Oncology 2019
The genomic landscape of pediatric cancers: Implications for diagnosis and treatment
EA Sweet-Cordero, JA Biegel
Science 2019
Cancer epigenetics: Moving forward
A Nebbioso, FP Tambaro, C DellAversana, L Altucci, JM Greally
PLoS genetics 2018
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
MJ McBride, JL Pulice, HC Beird, DR Ingram, AR DAvino, JF Shern, GW Charville, JL Hornick, RT Nakayama, EM Garcia-Rivera, DM Araujo, WL Wang, JW Tsai, M Yeagley, AJ Wagner, PA Futreal, J Khan, AJ Lazar, C Kadoch
Cancer Cell 2018
The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application
Y YAMADA, Y YAMADA
Proceedings of the Japan Academy, Series B 2018
The asymmetrically segregating lncRNA cherub is required for transforming stem cells into malignant cells
L Landskron, V Steinmann, F Bonnay, TR Burkard, J Steinmann, I Reichardt, H Harzer, AS Laurenson, H Reichert, JA Knoblich
eLife 2018
Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous
EM Pinto, D Hamideh, A Bahrami, BA Orr, T Lin, S Pounds, GP Zambetti, AS Pappo, A Gajjar, S Agnihotri, A Broniscer
Acta Neuropathologica 2018
Cherub versus brat
JA Malin, C Desplan
eLife 2018
The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex
S Sammak, MD Allen, N Hamdani, M Bycroft, G Zinzalla
The FEBS journal 2018
Case-based review: atypical teratoid/rhabdoid tumor
CL Nesvick, AA Rao, A Raghunathan, JA Biegel, DJ Daniels
Neuro-Oncology Practice 2018
Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia
N Potter, L Jones, H Blair, S Strehl, CJ Harrison, M Greaves, L Kearney, LJ Russell
Leukemia 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers
R Groisberg, DS Hong, J Roszik, F Janku, AM Tsimberidou, M Javle, F Meric-Bernstam, V Subbiah
Molecular cancer therapeutics 2018
Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution
S Venkatesan, C Swanton, BS Taylor, JF Costello
Cold Spring Harbor Perspectives in Medicine 2017
Integrating RNA sequencing into neuro-oncology practice
DS Rogawski, NA Vitanza, AC Gauthier, V Ramaswamy, C Koschmann
Translational Research 2017
Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib
S Vyse, F McCarthy, M Broncel, A Paul, JP Wong, A Bhamra, PH Huang
Journal of Proteomics 2017
Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model
Z Yang, M Jia, G Liu, H Hao, L Chen, G Li, S Liu, Y Li, CI Wu, X Lu, S Wang, CM Wong
PloS one 2017
Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex
P Sen, J Luo, A Hada, SG Hailu, ML Dechassa, J Persinger, S Brahma, S Paul, J Ranish, B Bartholomew
Cell Reports 2017
SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors
A Jeibmann, J Schulz, K Eikmeier, PD Johann, K Thiel, I Tegeder, O Ambrée, MC Frühwald, SM Pfister, M Kool, W Paulus, M Hasselblatt
Journal of Neuro-Oncology 2017
PGBD5 promotes site-specific oncogenic mutations in human tumors
AG Henssen, R Koche, J Zhuang, E Jiang, C Reed, A Eisenberg, E Still, IC MacArthur, E Rodríguez-Fos, S Gonzalez, M Puiggròs, AN Blackford, CE Mason, E Stanchina, M Gönen, AK Emde, M Shah, K Arora, C Reeves, ND Socci, E Perlman, CR Antonescu, CW Roberts, H Steen, E Mullen, SP Jackson, D Torrents, Z Weng, SA Armstrong, A Kentsis
Nature Genetics 2017
Modeling and Targeting MYC Genes in Childhood Brain Tumors
S Hutter, S Bolin, H Weishaupt, F Swartling
Genes & development 2017
Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment
C Dardis, J Yeo, K Milton, LS Ashby, KA Smith, S Mehta, E Youssef, J Eschbacher, K Tucker, L Dawes, N Lambie, E Algar, E Hovey
Frontiers in neurology 2017
The whole-genome landscape of medulloblastoma subtypes
PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, T Ehrenberger, S Gröbner, M Segura-Wang, T Zichner, VA Rudneva, HJ Warnatz, N Sidiropoulos, AH Phillips, S Schumacher, K Kleinheinz, SM Waszak, S Erkek, DT Jones, BC Worst, M Kool, M Zapatka, N Jäger, L Chavez, B Hutter, M Bieg, N Paramasivam, M Heinold, Z Gu, N Ishaque, C Jäger-Schmidt, CD Imbusch, A Jugold, D Hübschmann, T Risch, V Amstislavskiy, FG Gonzalez, UD Weber, S Wolf, GW Robinson, X Zhou, G Wu, D Finkelstein, Y Liu, FM Cavalli, B Luu, V Ramaswamy, X Wu, J Koster, M Ryzhova, YJ Cho, SL Pomeroy, C Herold-Mende, M Schuhmann, M Ebinger, LM Liau, J Mora, RE McLendon, N Jabado, T Kumabe, E Chuah, Y Ma, RA Moore, AJ Mungall, KL Mungall, N Thiessen, K Tse, T Wong, SJ Jones, O Witt, T Milde, AV Deimling, D Capper, A Korshunov, ML Yaspo, R Kriwacki, A Gajjar, J Zhang, R Beroukhim, E Fraenkel, JO Korbel, B Brors, M Schlesner, R Eils, MA Marra, SM Pfister, MD Taylor, P Lichter
Nature 2017
Emerging Opportunities for Target Discovery in Rare Cancers
T Sharifnia, AL Hong, CA Painter, JS Boehm
Cell Chemical Biology 2017
Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
J Vitte, F Gao, G Coppola, AR Judkins, M Giovannini
Nature Communications 2017
Epigenetic Alterations in Bone and Soft Tissue Tumors:
J Wojcik, K Cooper
Advances in Anatomic Pathology 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
W Richer, J Masliah-Planchon, N Clement, I Jimenez, L Maillot, D Gentien, B Albaud, W Chemlali, C Galant, F Larousserie, P Boudou-Rouquette, A Leruste, C Chauvin, ZY Han, JM Coindre, P Varlet, P Freneaux, D Ranchère-Vince, O Delattre, F Bourdeaut
Oncotarget 2017
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
HC Hodges, BZ Stanton, K Cermakova, CY Chang, EL Miller, JG Kirkland, WL Ku, V Veverka, K Zhao, GR Crabtree
Nature Structural & Molecular Biology 2017
Transposase-driven rearrangements in human tumors
SC Mack, H Suzuki, MD Taylor
Nature Genetics 2017
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
ZY Han, W Richer, P Fréneaux, C Chauvin, C Lucchesi, D Guillemot, C Grison, D Lequin, G Pierron, J Masliah-Planchon, A Nicolas, D Ranchère-Vince, P Varlet, S Puget, I Janoueix-Lerosey, O Ayrault, D Surdez, O Delattre, F Bourdeaut
Nature Communications 2016
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
X Wang, RS Lee, BH Alver, JR Haswell, S Wang, J Mieczkowski, Y Drier, SM Gillespie, TC Archer, JN Wu, EP Tzvetkov, EC Troisi, SL Pomeroy, JA Biegel, MY Tolstorukov, BE Bernstein, PJ Park, CW Roberts
Nature Genetics 2016
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer
C Hodges, JG Kirkland, GR Crabtree
Cold Spring Harbor Perspectives in Medicine 2016
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
K Giannikou, IA Malinowska, TJ Pugh, R Yan, YY Tseng, C Oh, J Kim, ME Tyburczy, Y Chekaluk, Y Liu, N Alesi, GA Finlay, CL Wu, S Signoretti, M Meyerson, G Getz, JS Boehm, EP Henske, DJ Kwiatkowski, GS Barsh
PLoS genetics 2016
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
AP Feinberg, MA Koldobskiy, A Göndör
Nature Reviews Genetics 2016
MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation
A Stojanova, WB Tu, R Ponzielli, M Kotlyar, PK Chan, PC Boutros, F Khosravi, I Jurisica, B Raught, LZ Penn
Cell cycle (Georgetown, Tex.) 2016
Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
HJ Chun, EL Lim, A Heravi-Moussavi, S Saberi, KL Mungall, M Bilenky, A Carles, K Tse, I Shlafman, K Zhu, JQ Qian, DL Palmquist, A He, W Long, R Goya, M Ng, VG LeBlanc, E Pleasance, N Thiessen, T Wong, E Chuah, YJ Zhao, JE Schein, DS Gerhard, MD Taylor, AJ Mungall, RA Moore, Y Ma, SJ Jones, EJ Perlman, M Hirst, MA Marra
Cancer Cell 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, F Holst, TI Zack, HM Werner, KM Staby, M Rosenberg, IM Stefansson, K Kusonmano, A Chevalier, KK Mauland, J Trovik, C Krakstad, M Giannakis, E Hodis, K Woie, L Bjorge, OK Vintermyr, JA Wala, MS Lawrence, G Getz, SL Carter, R Beroukhim, HB Salvesen
Nature Genetics 2016
INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases
JK Wasserman, BC Dickson, B Perez-Ordonez, JR de Almeida, JC Irish, I Weinreb
Head and Neck Pathology 2016
Distinct mutation accumulation rates among tissues determine the variation in cancer risk
D Hao, L Wang, L Di
Scientific Reports 2016
Prognostic factors and survival in non-central nervous system rhabdoid tumors
BA Farber, N Shukla, II Lim, JM Murphy, MP la Quaglia
Journal of Pediatric Surgery 2016
Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma
A Mariño-Enríquez, JV Bovée
Surgical Pathology Clinics 2016
Secondary EWSR1 gene abnormalities in SMARCB1 -deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results: EWSR1 Abnormalities in SMARCB1 -Deleted Tumors
SC Huang, L Zhang, YS Sung, CL Chen, YC Kao, NP Agaram, CR Antonescu
Genes Chromosomes and Cancer 2016
A Molecular Take on Malignant Rhabdoid Tumors
M Tang, RG Verhaak
Trends in Cancer 2016
Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies
MC Frühwald, JA Biegel, F Bourdeaut, CW Roberts, SN Chi
Neuro-Oncology 2016
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research
W Chang, AS Brohl, R Patidar, S Sindiri, JF Shern, JS Wei, YK Song, ME Yohe, B Gryder, S Zhang, KA Calzone, N Shivaprasad, X Wen, TC Badgett, M Miettinen, KR Hartman, JC League-Pascual, TN Trahair, BC Widemann, MS Merchant, RN Kaplan, JC Lin, J Khan
Clinical cancer research 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, JD Norman, P Guilhamon, L Garzia, NR Agamez, M Lu, TS Chan, D Picard, P Antonellis, DA Khuong-Quang, AC Planello, C Zeller, D Barsyte-Lovejoy, L Lafay-Cousin, L Letourneau, M Bourgey, M Yu, DM Gendoo, M Dzamba, M Barszczyk, T Medina, AN Riemenschneider, AS Morrissy, YS Ra, V Ramaswamy, M Remke, CP Dunham, S Yip, H Ng, JQ Lu, V Mehta, S Albrecht, J Pimentel, JA Chan, GR Somers, CC Faria, L Roque, M Fouladi, LM Hoffman, AS Moore, Y Wang, SA Choi, JR Hansford, D Catchpoole, DK Birks, NK Foreman, D Strother, A Klekner, L Bognár, M Garami, P Hauser, T Hortobágyi, B Wilson, J Hukin, AS Carret, TE van Meter, EI Hwang, A Gajjar, SH Chiou, H Nakamura, H Toledano, I Fried, D Fults, T Wataya, C Fryer, DD Eisenstat, K Scheinemann, AJ Fleming, DL Johnston, J Michaud, S Zelcer, R Hammond, S Afzal, DA Ramsay, N Sirachainan, S Hongeng, N Larbcharoensub, RG Grundy, RR Lulla, JR Fangusaro, H Druker, U Bartels, R Grant, D Malkin, CJ McGlade, T Nicolaides, T Tihan, J Phillips, J Majewski, A Montpetit, G Bourque, GD Bader, AT Reddy, GY Gillespie, M Warmuth-Metz, S Rutkowski, U Tabori, M Lupien, M Brudno, U Schüller, T Pietsch, AR Judkins, CE Hawkins, E Bouffet, SK Kim, PB Dirks, MD Taylor, A Erdreich-Epstein, CH Arrowsmith, DD de Carvalho, JT Rutka, N Jabado, A Huang
Cancer Cell 2016
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
JP Wong, JR Todd, MA Finetti, F McCarthy, M Broncel, S Vyse, MT Luczynski, S Crosier, KA Ryall, K Holmes, LS Payne, F Daley, P Wai, A Jenks, B Tanos, AC Tan, RC Natrajan, D Williamson, PH Huang
Cell Reports 2016
Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22
HM Byers, MP Adam, A LaCroix, SE Leary, B Cole, WB Dobyns, HC Mefford
American journal of medical genetics. Part A 2016
The SWI/SNF Complex Protein Snr1 Is a Tumor Suppressor in Drosophila Imaginal Tissues
G Xie, H Chen, D Jia, Z Shu, WH Palmer, YC Huang, X Zeng, SX Hou, R Jiao, WM Deng
Cancer research 2016
Genetics of Bladder Malignant Tumors in Childhood
A Zangari, J Zaini, C Gulia
Current genomics 2015
Evolutionary Determinants of Cancer
M Greaves
Cancer Discovery 2015
Control of cancer formation by intrinsic genetic noise and microenvironmental cues
A Brock, S Krause, DE Ingber
Nature Reviews Cancer 2015
Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics
MA Smith, GH Reaman
Pediatric Clinics of North America 2015
Oncotator: Cancer Variant Annotation Tool
AH Ramos, L Lichtenstein, M Gupta, MS Lawrence, TJ Pugh, G Saksena, M Meyerson, G Getz
Human Mutation 2015
The effects of chromatin organization on variation in mutation rates in the genome
KD Makova, RC Hardison
Nature Reviews Genetics 2015
Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies
LM Hoffman, R Salloum, M Fouladi
Current Neurology and Neuroscience Reports 2015
Protein Domain-Level Landscape of Cancer-Type-Specific Somatic Mutations
F Yang, E Petsalaki, T Rolland, DE Hill, M Vidal, FP Roth, M Singh
PLoS computational biology 2015
A Rare Case of Undifferentiated Carcinoma of the Colon with Rhabdoid Features: A Case Report and Review of the Literature
E Moussaly, JP Atallah
Case Reports in Oncological Medicine 2015
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
J Noujaim, K Thway, Z Bajwa, A Bajwa, RG Maki, RL Jones, C Keller
Frontiers in Oncology 2015
Detection of a Distinctive Genomic Signature in Rhabdoid Glioblastoma, A Rare Disease Entity Identified by Whole Exome Sequencing and Whole Transcriptome Sequencing
Y Koh, I Park, CH Sun, S Lee, H Yun, CK Park, SH Park, JK Park, SH Lee
Translational oncology 2015
Atypical teratoid rhabdoid tumors of the posterior fossa in children
AJ DiPatri, ST Sredni, G Grahovac, T Tomita
Child's Nervous System 2015
Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
J Darr, A Klochendler, S Isaac, T Geiger, A Eden
Molecular Cancer 2015
Exome Sequencing of an Adult Pituitary Atypical Teratoid Rhabdoid Tumor
S Biswas, M Wood, A Joshi, N Bown, L Strain, T Martinsson, J Campbell, A Ashworth, A Swain
Frontiers in Oncology 2015
An epigenetic gateway to brain tumor cell identity
SC Mack, CG Hubert, TE Miller, MD Taylor, JN Rich
Nature Neuroscience 2015
Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency
J Sandgren, S Holm, AM Marino, J Asmundsson, P Grillner, M Nistér, TD de Ståhl
BioMed Research International 2015
Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53
JM Ng, D Martinez, ED Marsh, Z Zhang, E Rappaport, M Santi, T Curran
Cancer research 2015
Biology and Treatment of Rhabdoid Tumor
Geller JI, Roth JJ, Biegel JA
Critical Reviews in Oncogenesis 2015
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
Fahiminiya S, Witkowski L, Nadaf J, Carrot-Zhang J, Goudie C, Hasselblatt M, Johann P, Kool M, Lee RS, Gayden T, Roberts CW, Biegel JA, Jabado N, Majewski J, Foulkes WD
Oncotarget 2015
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
KH Kim, CW Roberts
Cancer Genetics 2014
Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
KC Helming, X Wang, CW Roberts
Cancer Cell 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, M Gallo, L Garzia, K Zayne, X Zhang, V Ramaswamy, N Jäger, DT Jones, M Sill, TJ Pugh, M Ryzhova, KM Wani, DJ Shih, R Head, M Remke, SD Bailey, T Zichner, CC Faria, M Barszczyk, S Stark, H Seker-Cin, S Hutter, P Johann, S Bender, V Hovestadt, T Tzaridis, AM Dubuc, PA Northcott, J Peacock, KC Bertrand, S Agnihotri, FM Cavalli, I Clarke, K Nethery-Brokx, CL Creasy, SK Verma, J Koster, X Wu, Y Yao, T Milde, P Sin-Chan, J Zuccaro, L Lau, S Pereira, P Castelo-Branco, M Hirst, MA Marra, SS Roberts, D Fults, L Massimi, YJ Cho, TV Meter, W Grajkowska, B Lach, AE Kulozik, A Deimling, O Witt, SW Scherer, X Fan, KM Muraszko, M Kool, SL Pomeroy, N Gupta, J Phillips, A Huang, U Tabori, C Hawkins, D Malkin, PN Kongkham, WA Weiss, N Jabado, JT Rutka, E Bouffet, JO Korbel, M Lupien, KD Aldape, GD Bader, R Eils, P Lichter, PB Dirks, SM Pfister, A Korshunov, MD Taylor
Nature 2014
Diffuse intrinsic pontine glioma: a reassessment
NJ Robison, MW Kieran
Journal of Neuro-Oncology 2014
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material: SMARCB1 Homozygous Deletions in Epithelioid Sarcoma
FL Loarer, L Zhang, CD Fletcher, A Ribeiro, S Singer, A Italiano, A Neuville, A Houlier, F Chibon, JM Coindre, CR Antonescu
Genes Chromosomes and Cancer 2014
Advances in Cancer Research
K Mayes, Z Qiu, A Alhazmi, JW Landry
Advances in cancer research 2014
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
L Witkowski, J Carrot-Zhang, S Albrecht, S Fahiminiya, N Hamel, E Tomiak, D Grynspan, E Saloustros, J Nadaf, B Rivera, C Gilpin, E Castellsagué, R Silva-Smith, F Plourde, M Wu, A Saskin, M Arseneault, RG Karabakhtsian, EA Reilly, FR Ueland, A Margiolaki, K Pavlakis, SM Castellino, J Lamovec, HJ Mackay, LM Roth, TM Ulbright, TA Bender, V Georgoulias, M Longy, A Berchuck, M Tischkowitz, I Nagel, R Siebert, CJ Stewart, J Arseneau, WG McCluggage, BA Clarke, Y Riazalhosseini, M Hasselblatt, J Majewski, WD Foulkes
Nature Genetics 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
S Venneti, M Santi, MM Felicella, D Yarilin, JJ Phillips, LM Sullivan, D Martinez, A Perry, PW Lewis, CB Thompson, AR Judkins
Acta Neuropathologica 2014
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
NJ Roberts, L Zhang, F Janku, A Collins, RY Bai, V Staedtke, AW Rusk, D Tung, M Miller, J Roix, KV Khanna, R Murthy, RS Benjamin, T Helgason, AD Szvalb, JE Bird, S Roy-Chowdhuri, HH Zhang, Y Qiao, B Karim, J McDaniel, A Elpiner, A Sahora, J Lachowicz, B Phillips, A Turner, MK Klein, G Post, LA Diaz, GJ Riggins, N Papadopoulos, KW Kinzler, B Vogelstein, C Bettegowda, DL Huso, M Varterasian, S Saha, S Zhou
Science Translational Medicine 2014
SWI/SNF chromatin remodeling complexes and cancer: AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS)
JA Biegel, TM Busse, BE Weissman
American Journal of Medical Genetics Part C Seminars in Medical Genetics 2014
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours
D Rakheja, KS Chen, Y Liu, AA Shukla, V Schmid, TC Chang, S Khokhar, JE Wickiser, NJ Karandikar, JS Malter, JT Mendell, JF Amatruda
Nature Communications 2014
The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation
AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, L Hurd, L Chen, JF Shern, H Liao, X Wen, J Gerard, JS Kim, JA Guerrero, I Machado, DH Wai, P Picci, T Triche, AE Horvai, M Miettinen, JS Wei, D Catchpool, A Llombart-Bosch, T Waldman, J Khan
PLoS genetics 2014
Wnt pathway in atypical teratoid rhabdoid tumors
M Chakravadhanula, CN Hampton, P Chodavadia, V Ozols, L Zhou, D Catchpoole, J Xu, A Erdreich-Epstein, RD Bhardwaj
Neuro-Oncology 2014
Concise Review: Dedifferentiation Meets Cancer Development: Proof of Concept for Epigenetic Cancer
Y Yamada, H Haga, Y Yamada
Stem Cells Translational Medicine 2014
SNF5/INI1 Deficiency Redefines Chromatin Remodeling Complex Composition during Tumor Development
D Wei, D Goldfarb, S Song, C Cannon, F Yan, D Sakellariou-Thompson, M Emanuele, MB Major, BE Weissman, Y Kuwahara
Molecular cancer research : MCR 2014
Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor
F Jamshidi, E Pleasance, Y Li, Y Shen, K Kasaian, R Corbett, P Eirew, A Lum, P Pandoh, Y Zhao, JE Schein, RA Moore, R Rassekh, DG Huntsman, M Knowling, H Lim, DJ Renouf, SJ Jones, MA Marra, TO Nielsen, J Laskin, S Yip
The oncologist 2014
Loss of Smarc Proteins Impairs Cerebellar Development
N Moreno, C Schmidt, J Ahlfeld, J Poschl, S Dittmar, SM Pfister, M Kool, K Kerl, U Schuller
The Journal of neuroscience : the official journal of the Society for Neuroscience 2014
Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion
KR Bosse, AR Shukla, B Pawel, KR Chikwava, M Santi, L Tooke, K Castagna, JA Biegel, R Bagatell
Cancer Genetics 2014
Tumours outside the mutation box
R Versteeg
Nature 2014
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, Orr BA, Eberhart CG, Biegel JA, Raabe EH
Oncotarget 2014
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors.
Kahali B, Yu J, Marquez SB, Thompson KW, Liang SY, Lu L, Reisman D
Oncotarget 2014
The genomic landscape of small intestine neuroendocrine tumors
Michaela Banck, Rahul Kanwar, Amit Kulkarni, Ganesh Boora, Franziska Metge, Benjamin Kipp, Lizhi Zhang, Erik Thorland, Kay Minn, Ramesh Tentu, Bruce Eckloff, Eric Wieben, Yanhong Wu, Julie Cunningham, David Nagorney, Judith Gilbert, Matthew Ames, Andreas Beutler
Journal of Clinical Investigation 2013
Rhabdoid Tumors: An Initial Clue to the Role of Chromatin Remodeling in Cancer: Rhabdoid Tumors and the Role of Chromatin Remodeling in Cancer
RS Lee, CW Roberts
Brain Pathology 2013
Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer--Mechanisms and Potential Therapeutic Insights
X Wang, JR Haswell, CW Roberts
Clinical cancer research 2013
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
K Cibulskis, MS Lawrence, SL Carter, A Sivachenko, D Jaffe, C Sougnez, S Gabriel, M Meyerson, ES Lander, G Getz
Nature Biotechnology 2013
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, SL Carter, K Cibulskis, M Hanna, A Kiezun, J Kim, MS Lawrence, L Lichenstein, A McKenna, CS Pedamallu, AH Ramos, E Shefler, A Sivachenko, C Sougnez, C Stewart, A Ally, I Birol, R Chiu, RD Corbett, M Hirst, SD Jackman, B Kamoh, AH Khodabakshi, M Krzywinski, A Lo, RA Moore, KL Mungall, J Qian, A Tam, N Thiessen, Y Zhao, KA Cole, M Diamond, SJ Diskin, YP Mosse, AC Wood, L Ji, R Sposto, T Badgett, WB London, Y Moyer, JM Gastier-Foster, MA Smith, JM Auvil, DS Gerhard, MD Hogarty, SJ Jones, ES Lander, SB Gabriel, G Getz, RC Seeger, J Khan, MA Marra, M Meyerson, JM Maris
Nature Genetics 2013
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
SK Knutson, NM Warholic, TJ Wigle, CR Klaus, CJ Allain, A Raimondi, MP Scott, R Chesworth, MP Moyer, RA Copeland, VM Richon, RM Pollock, KW Kuntz, H Keilhack
Proceedings of the National Academy of Sciences 2013
Die neue WHO-Klassifikation und aktuelle Ergebnisse in der Weichteiltumorpathologie
I Petersen
Der Pathologe 2013
Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
EL Mora-Blanco, Y Mishina, EJ Tillman, YJ Cho, CS Thom, SL Pomeroy, W Shao, CW Roberts
Oncogene 2013
Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters
MY Tolstorukov, CG Sansam, P Lu, EC Koellhoffer, KC Helming, BH Alver, EJ Tillman, JA Evans, BG Wilson, PJ Park, CW Roberts
Proceedings of the National Academy of Sciences 2013
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
K Kerl, D Ries, R Unland, C Borchert, N Moreno, M Hasselblatt, H Jürgens, M Kool, D Görlich, M Eveslage, M Jung, M Meisterernst, M Frühwald
BMC Cancer 2013
Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor
P Modena, I Sardi, M Brenca, L Giunti, AM Buccoliero, B Pollo, V Biassoni, L Genitori, M Antonelli, R Maestro, F Giangaspero, M Massimino
BMC Cancer 2013
NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi
C Charbel, RH Fontaine, GG Malouf, A Picard, N Kadlub, N El-Murr, A How-Kit, X Su, A Coulomb-L'hermine, J Tost, S Mourah, S Aractingi, S Guégan
Journal of Investigative Dermatology 2013
Linking the SWI/SNF complex to prostate cancer
RS Lee, CW Roberts
Nature Genetics 2013
Landscape of genomic alterations in cervical carcinomas
AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu, I Imaz-Rosshandler, TJ Pugh, AD Cherniack, L Ambrogio, K Cibulskis, B Bertelsen, S Romero-Cordoba, V Treviño, K Vazquez-Santillan, AS Guadarrama, AA Wright, MW Rosenberg, F Duke, B Kaplan, R Wang, E Nickerson, HM Walline, MS Lawrence, C Stewart, SL Carter, A McKenna, IP Rodriguez-Sanchez, M Espinosa-Castilla, K Woie, L Bjorge, E Wik, MK Halle, EA Hoivik, C Krakstad, NB Gabiño, GS Gómez-Macías, LD Valdez-Chapa, ML Garza-Rodríguez, G Maytorena, J Vazquez, C Rodea, A Cravioto, ML Cortes, H Greulich, CP Crum, DS Neuberg, A Hidalgo-Miranda, CR Escareno, LA Akslen, TE Carey, OK Vintermyr, SB Gabriel, HA Barrera-Saldaña, J Melendez-Zajgla, G Getz, HB Salvesen, M Meyerson
Nature 2013
Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors
S Wöhrle, A Weiss, M Ito, A Kauffmann, M Murakami, Z Jagani, A Thuery, B Bauer-Probst, F Reimann, C Stamm, A Pornon, V Romanet, V Guagnano, T Brümmendorf, WR Sellers, F Hofmann, CW Roberts, DG Porta
PloS one 2013
The SWI/SNF tumor suppressor complex
P Lu, CW Roberts
Nucleus 2013
A Comparative Genomic Approach for Identifying Synthetic Lethal Interactions in Human Cancer
R Deshpande, MK Asiedu, M Klebig, S Sutor, E Kuzmin, J Nelson, J Piotrowski, SH Shin, M Yoshida, M Costanzo, C Boone, DA Wigle, CL Myers
Cancer research 2013
SNF5 Reexpression in Malignant Rhabdoid Tumors Regulates Transcription of Target Genes by Recruitment of SWI/SNF Complexes and RNAPII to the Transcription Start Site of Their Promoters
Y Kuwahara, D Wei, J Durand, BE Weissman
Molecular cancer research : MCR 2013
The Potent Oncogene NPM-ALK Mediates Malignant Transformation of Normal Human CD4+ T Lymphocytes
Zhang Q, Wei F, Wang HY, Liu X, Roy D, Xiong QB, Jiang S, Medvec A, Danet-Desnoyers G, Watt C, Tomczak E, Kalos M, Riley JL, Wasik MA
The American Journal of Pathology 2013
Introduction
Brain Pathology 2013
Medulloblastoma biology in the post-genomic era
TC Archer, SL Pomeroy
Future Oncology 2012
Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions
KF Ginn, A Gajjar
Frontiers in Oncology 2012
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
Referenced in 5 patents
On 1 Facebook pages
Referenced by 1 Bluesky users
239 readers on Mendeley
1 readers on CiteULike
See more details